{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Amanda J Cross, Emma C Robbins, Kevin Pack, Iain Stenson, Paula L Kirby, Bhavita Patel, Matthew D Rutter, Andrew M Veitch, Brian P Saunders, Matthew Little, Alastair Gray, Stephen W Duffy & Kate Wooldrage.

Amanda J Cross ^1,*, Emma C Robbins ¹, Kevin Pack ¹, Iain Stenson ¹, Paula L Kirby ¹, Bhavita Patel ¹, Matthew D Rutter ^2,3, Andrew M Veitch ⁴, Brian P Saunders ⁵, Matthew Little ⁶, Alastair Gray ⁶, Stephen W Duffy ⁷, Kate Wooldrage ¹

¹ Cancer Screening and Prevention Research Group, Department of Surgery and Cancer, Imperial College London, London, UK
² Department of Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK
³ Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK
⁴ Department of Gastroenterology, New Cross Hospital, Wolverhampton, UK
⁵ Wolfson Unit for Endoscopy, St Mark’s Hospital, London, UK
⁶ Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK
⁷ Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK
^* Corresponding author Email: amanda.cross1@imperial.ac.uk

Declared competing interests of authors: Amanda J Cross receives funding from Cancer Research UK (London, UK) (Population Research Committee – Programme Award C53889/A25004). Matthew D Rutter reports speaker honoraria from Swiss SCWeb AG (Lucerne, Switzerland) and PENTAX Medical (Tokyo, Japan), a grant from Olympus Corporation (Tokyo, Japan) and consultancy fees from Norgine BV (Amsterdam, the Netherlands) outside the submitted work. Brian P Saunders reports research grants, personal fees and non-financial support from Olympus Corporation, personal fees from Boston Scientific Corporation (Marlborough, MA, USA), Creo Medical Group plc (Chepstow, UK) and Norgine BV, a patent and royalty agreement with Diagmed Healthcare Ltd (Thirsk, UK) and Creo Medical Group plc, and equity in Creo Medical Group plc outside the submitted work. Alastair Gray is partly funded by the National Institute for Health and Care Research Biomedical Research Centre (Oxford, UK) and is a member of the UK National Screening Committee (London, UK) (2015–present).